BC
IPXL

Brinker Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Brinker Capital’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,800
Closed -$405K – 1041
2018
Q1 		$405K Buy
20,800
+2,909
+16% +$57.1K 0.02% 775
2017
Q4 		$298K Buy
+17,891
New +$328K 0.01% 852

Brinker Capital's IPXL Position: Q2 2018 in Review

Brinker Capital sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 20,800 shares — an estimated $405K sold.

Brinker Capital first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $405K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Brinker Capital reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Brinker Capital sold 20,800 Impax Laboratories, Inc. shares in Q2 2018, an estimated $405K.
  • Brinker Capital first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
  • Brinker Capital's Impax Laboratories, Inc. position peaked at $405K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Brinker Capital's 13F filing for Q2 2018, filed 13 Aug 2018.